References
[1] Coronaviridae Study Group of
the International Committee on Taxonomy of V. The species Severe acute
respiratory syndrome-related coronavirus: classifying 2019-nCoV and
naming it SARS-CoV-2. Nat Microbiol 2020; 5: 536-544.
[2] Wu F, Zhao S, Yu B, Chen YM,
Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai
FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC and Zhang YZ. A new
coronavirus associated with human respiratory disease in China. Nature
2020; 579: 265-269.
[3] Zhu N, Zhang D, Wang W, Li X,
Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang
D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus I and Research T.
A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl
J Med 2020; 382: 727-733.
[4] Zhou P, Yang XL, Wang XG, Hu
B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo
Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K,
Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF and Shi ZL. A
pneumonia outbreak associated with a new coronavirus of probable bat
origin. Nature 2020; 579: 270-273.
[5] He J, Tao H, Yan Y, Huang SY
and Xiao Y. Molecular Mechanism of Evolution and Human Infection with
SARS-CoV-2. Viruses 2020; 12:
[6] Nishiura H, Jung SM, Linton
NM, Kinoshita R, Yang Y, Hayashi K, Kobayashi T, Yuan B and Akhmetzhanov
AR. The Extent of Transmission of Novel Coronavirus in Wuhan, China,
2020. J Clin Med 2020; 9:
[7] Hui DS, E IA, Madani TA,
Ntoumi F, Kock R, Dar O, Ippolito G, McHugh TD, Memish ZA, Drosten C,
Zumla A and Petersen E. The continuing 2019-nCoV epidemic threat of
novel coronaviruses to global health - The latest 2019 novel coronavirus
outbreak in Wuhan, China. Int J Infect Dis 2020; 91: 264-266.
[8] Corman VM, Landt O, Kaiser M,
Molenkamp R, Meijer A, Chu DK, Bleicker T, Brunink S, Schneider J,
Schmidt ML, Mulders DG, Haagmans BL, van der Veer B, van den Brink S,
Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens
H, Reusken C, Koopmans MP and Drosten C. Detection of 2019 novel
coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 2020; 25:
[9] Lu G and Wang J. Dynamic
changes in routine blood parameters of a severe COVID-19 case. Clin Chim
Acta 2020; 508: 98-102.
[10] Chan JF, Kok KH, Zhu Z, Chu
H, To KK, Yuan S and Yuen KY. Genomic characterization of the 2019 novel
human-pathogenic coronavirus isolated from a patient with atypical
pneumonia after visiting Wuhan. Emerg Microbes Infect 2020; 9: 221-236.
[11] Zheng J. SARS-CoV-2: an
Emerging Coronavirus that Causes a Global Threat. Int J Biol Sci 2020;
16: 1678-1685.
[12] Lu R, Huang T, Hu H and Liu
XP. Patients with mild and general COVID-19 should be negative for at
least 3 consecutive nucleic acid tests before discharged. PLoS One 2020;
15: e0240081.
[13] Wang W, Tang J and Wei F.
Updated understanding of the outbreak of 2019 novel coronavirus
(2019-nCoV) in Wuhan, China. J Med Virol 2020; 92: 441-447.
[14] Huang C, Wang Y, Li X, Ren
L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei
Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G,
Jiang R, Gao Z, Jin Q, Wang J and Cao B. Clinical features of patients
infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:
497-506.
[15] Chen N, Zhou M, Dong X, Qu
J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X and
Zhang L. Epidemiological and clinical characteristics of 99 cases of
2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
Lancet 2020; 395: 507-513.
[16] Wang D, Hu B, Hu C, Zhu F,
Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X
and Peng Z. Clinical Characteristics of 138 Hospitalized Patients With
2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020;
[17] Chen G, Wu D, Guo W, Cao Y,
Huang D, Wang H, Wang T, Zhang X, Chen H, Yu H, Zhang X, Zhang M, Wu S,
Song J, Chen T, Han M, Li S, Luo X, Zhao J and Ning Q. Clinical and
immunological features of severe and moderate coronavirus disease 2019.
J Clin Invest 2020; 130: 2620-2629.
[18] Tan L, Wang Q, Zhang D, Ding
J, Huang Q, Tang YQ, Wang Q and Miao H. Lymphopenia predicts disease
severity of COVID-19: a descriptive and predictive study. Signal
Transduct Target Ther 2020; 5: 33.
[19] Li Y, Yang T, Wang S, Zheng
J, Zhou J, Jiang M, Zhou T, Cao Y and Wang H. The value of lymphocyte
count in determining the severity of COVID-19 and estimating the time
for nucleic acid test results to turn negative. Bosn J Basic Med Sci
2020;
[20] Chen W, Lan Y, Yuan X, Deng
X, Li Y, Cai X, Li L, He R, Tan Y, Deng X, Gao M, Tang G, Zhao L, Wang
J, Fan Q, Wen C, Tong Y, Tang Y, Hu F, Li F and Tang X. Detectable
2019-nCoV viral RNA in blood is a strong indicator for the further
clinical severity. Emerg Microbes Infect 2020; 9: 469-473.
[21] Liu Y, Liao W, Wan L, Xiang
T and Zhang W. Correlation Between Relative Nasopharyngeal Virus RNA
Load and Lymphocyte Count Disease Severity in Patients with COVID-19.
Viral Immunol 2020;
[22] Wagner J, DuPont A, Larson
S, Cash B and Farooq A. Absolute lymphocyte count is a prognostic marker
in Covid-19: A retrospective cohort review. Int J Lab Hematol 2020; 42:
761-765.